Finance

Lists
CHEOY:OTCMKTS
Cochlear Ord ADR
45,45 $
+1,63%
(+0,73) 1D
16 қаз., 12:27:12 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHEOY...
Open
43,84 $
High
46,04 $
Low
43,84 $
Mkt. cap
8,58 млрд
Avg. vol.
18,60 мың
Volume
2,99 мың
52-wk high
98,49 $
52-wk low
31,82 $
Beta
0,68
Shares outstanding
130,80 млн
No. of employees
5 мың
Open
43,84 $
High
46,04 $
Low
43,84 $
Mkt. cap
8,58 млрд
Avg. vol.
18,60 мың
Volume
2,99 мың
52-wk high
98,49 $
52-wk low
31,82 $
Beta
0,68
Shares outstanding
130,80 млн
No. of employees
5 мың
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
20 сағат бұрын
UBS keeps AUD 135.00 target for Cochlear stock
Simply Wall Street
Simply Wall Street
·
21 сағат бұрын
Cochlear And 2 Australian Healthcare Stocks To Watch
Stocks Down Under
Stocks Down Under
·
1 күн бұрын
Cochlear (ASX:COH) Share Price, Forecast & Analysis
Profile
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015. Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
About Cochlear Ord ADR
CEODig Howitt
Employees5,4 мың
Founded1981
HeadquartersСидней, Жаңа Оңтүстік Уэльс, Австралия
SectorMedical device
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
583,60 млн
583,60 млн
590,20 млн
590,20 млн
Cost of goods sold
159,60 млн
159,60 млн
184,40 млн
184,40 млн
Cost of revenue
159,60 млн
159,60 млн
184,40 млн
184,40 млн
Research and development expenses
76,40 млн
76,40 млн
85,20 млн
85,20 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
224,70 млн
224,70 млн
239,40 млн
239,40 млн
Operating expense
297,85 млн
297,85 млн
321,20 млн
321,20 млн
Total operating expenses
457,45 млн
457,45 млн
505,60 млн
505,60 млн
Operating income
126,15 млн
126,15 млн
84,60 млн
84,60 млн
Other non operating income
-
-
-
-
EBT including unusual items
106,55 млн
106,55 млн
400,00 м.
400,00 м.
EBT excluding unusual items
128,25 млн
128,25 млн
86,55 млн
86,55 млн
Income tax expense
25,80 млн
25,80 млн
7,50 млн
7,50 млн
Effective tax rate
24,21%
24,21%
1 875,00%
1 875,00%
Other operating expenses
-3,25 млн
-3,25 млн
-3,40 млн
-3,40 млн
Net income
80,75 млн
80,75 млн
-7,10 млн
-7,10 млн
Net profit margin
13,84%
13,84%
-1,20%
-1,20%
Earnings per share
-
-
-
-
Interest and investment income
4,20 млн
4,20 млн
900,00 м.
900,00 м.
Interest expense
-3,15 млн
-3,15 млн
-3,45 млн
-3,45 млн
Net interest expenses
1,05 млн
1,05 млн
-2,55 млн
-2,55 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
151,95 млн
151,95 млн
88,00 млн
88,00 млн
Gain or loss from assets sale
-
-
5,80 млн
5,80 млн
AI content may include mistakes. Learn more
Google қолданбалары